New vaccine trial aims to train body to fight returning prostate cancer
Disease control
Terminated
This early-stage trial tested a new vaccine called VTP-850 for men whose prostate cancer has started to return after initial surgery or radiation. The goal was to see if the vaccine is safe and if it can train the body's immune system to fight the cancer, which would be shown by …
Phase: PHASE1, PHASE2 • Sponsor: Barinthus Biotherapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC